ascofuranone and analogs (aRigen/DNDi)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameascofuranone and analogs (aRigen/DNDi)
Drug Alias Nametrypanosomiasis therapy (aRigen/DNDi)ascofuranoneARA-01
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsTrypanosomiasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerlandJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesArigen Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArigen Pharmaceuticals IncDrugs For Neglected Diseases Initiative
Active IndicationsN/A
Inactive IndicationsTrypanosomiasis

Other Information

ATC CodeN/A
Related LinksN/A